Found: 14
Select item for more details and to access through your institution.
318 Building A Better CAR: Improving CAR-T Trafficking in Cancer Therapy.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Novel Treatments for Mantle Cell Lymphoma: From Targeted Therapies to CAR T Cells.
- Published in:
- Drugs, 2021, v. 81, n. 6, p. 669, doi. 10.1007/s40265-021-01497-y
- By:
- Publication type:
- Article
Healthcare Utilization Disparities of Adolescent and Young Adults Compared to the Older Lymphoma Population.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 9, p. e260, doi. 10.1016/j.clml.2023.05.010
- By:
- Publication type:
- Article
Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 10, p. 753, doi. 10.1016/j.clml.2022.05.004
- By:
- Publication type:
- Article
Complications Associated With Dose-adjusted EPOCH-rituximab Therapy for Non-Hodgkin Lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Durability of Response in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel in the Pivotal Phase 2 Study, ZUMA-1.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S277, doi. 10.1016/j.clml.2018.07.206
- By:
- Publication type:
- Article
Axicabtagene Ciloleucel in Patients with Refractory Large B Cell Lymphoma: Outcomes by Prior Lines of Therapy in the Pivotal Phase 2 Study, ZUMA-1.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S276, doi. 10.1016/j.clml.2018.07.203
- By:
- Publication type:
- Article
Consolidative Radioimmunotherapy After Chemoimmunotherapy in Patients With Histologic Transformation of Indolent Non-Hodgkin Lymphoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy of lenalidomide in high‐risk diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 188, n. 4, p. e33, doi. 10.1111/bjh.16302
- By:
- Publication type:
- Article
PD-1<sup>Hi</sup> CAR-T cells provide superior protection against solid tumors.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1187850
- By:
- Publication type:
- Article
Cytopenia after CAR-T Cell Therapy—A Brief Review of a Complex Problem.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1501, doi. 10.3390/cancers14061501
- By:
- Publication type:
- Article
Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, Limitations, and New Directions.
- Published in:
- Oncology (08909091), 2017, v. 31, n. 5, p. 402
- By:
- Publication type:
- Article
Chimeric antigen receptor (CAR) T-cell treatment for mantle cell lymphoma (MCL).
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221080738
- By:
- Publication type:
- Article